Bioceltix Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Lukasz Bzdzion
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 7.4% |
| Management average tenure | no data |
| Board average tenure | 2.8yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -zł16m |
| Jun 30 2024 | n/a | n/a | -zł16m |
| Mar 31 2024 | n/a | n/a | -zł15m |
| Dec 31 2023 | n/a | n/a | -zł14m |
| Sep 30 2023 | n/a | n/a | -zł13m |
| Jun 30 2023 | n/a | n/a | -zł12m |
| Mar 31 2023 | n/a | n/a | -zł10m |
| Dec 31 2022 | zł368k | zł368k | -zł9m |
| Sep 30 2022 | n/a | n/a | -zł8m |
| Mar 31 2022 | n/a | n/a | -zł5m |
| Dec 31 2021 | zł269k | n/a | -zł4m |
Compensation vs Market: Insufficient data to establish whether Lukasz's total compensation is reasonable compared to companies of similar size in the Polish market.
Compensation vs Earnings: Lukasz's compensation has increased whilst the company is unprofitable.
CEO
Lukasz Bzdzion
no data
Tenure
zł367,523
Compensation
Mr. Lukasz Bzdzion is President of the Management Board of Bioceltix S.A. A biotechnologist and molecular biologist. An intern at the prestigious Medical College of Georgia (Center of Biotechnology and Gen...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Member of Supervisory Board | no data | zł13.76k | no data | |
| Member of Supervisory Board | 2.8yrs | zł33.23k | no data | |
| Member of Scientific Board | no data | no data | no data | |
| Member of Scientific Board | no data | no data | no data | |
| Member of Scientific Board | no data | no data | no data | |
| Chairman of Supervisory Board | 2.8yrs | zł33.87k | no data | |
| Member of Supervisory Board | 2.8yrs | zł25.34k | no data | |
| Vice Chairman of Supervisory Board | 2.8yrs | zł13.76k | no data | |
| Member of Supervisory Board | no data | zł13.76k | no data |
2.8yrs
Average Tenure
Experienced Board: BCX's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/07 07:18 |
| End of Day Share Price | 2025/01/07 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bioceltix S.A. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Beata Szparaga-Wasniewska | Biuro maklerskie mBanku |